85 Results
Sort By:
Published on September 25, 2019
Gene expression regulators work together to raise an individual’s risk of developing schizophrenia, according to new research. Scientists used CRISPR to simultaneously increase or decrease expression of several schizophrenia-implicated genes. That altered expression of more than 1,250 other genes. The magnitude of this effect was such that it suggests an underlying…
Published on May 30, 2019
Researchers at the University of Edinburgh and the European Bioinformatics Institute at the European Molecular Biology Laboratory (EMBL-EBI) have introduced a new diagnostic genome-wide sequence analysis software that significantly improves evaluating genetically heterogeneous clinical presentations. This new tool can identify specific genetic changes in the three billion base pairs of…
Published on March 26, 2019
A collaboration launched today by Illumina and the Lundbeck Foundation GeoGenetics Centre at the University of Copenhagen plans to generate and analyze one of the largest sets of ancient human and pathogen genome panels ever created—with the goal of underpinning new approaches to developing treatments for mental and neurological conditions.…
Published on August 30, 2018
As the U.S. marked the 242nd anniversary of its independence, the mother country also had reason to celebrate. England’s National Health Service commemorated its 70th birthday not with a cake or candles, but with a nicely timed announcement that the 70,000th genome had been sequenced of the 100,000 planned by…
Published on August 13, 2018
Scientists at University of Utah (U of U) Health report that they have developed high-tech tools to uncover the genetic cause of early infantile epileptic encephalopathy (EIEE). Their study (“Whole-genome analysis for effective clinical diagnosis and gene discovery in early infantile epileptic encephalopathy”) appears online in Nature Genomic Medicine. “Early infantile epileptic encephalopathy (EIEE)…
Published on July 6, 2017
Konica Minolta has agreed to acquire Ambry Genetics for up to $1 billion, the companies said today, in a deal the buyer envisions as the first step in its strategy of developing a leading presence in precision medicine. Founded in 1999, privately-held Ambry says it has performed more than one…
Published on April 12, 2017
Newly published researcher Centre for Addiction and Mental Health (CAMH) and Queen's University, Toronto, has identified 26 new genes linked to intellectual disability. The study “Mapping Autosomal Recessive Intellectual Disability: Combined Microarray and Exome Sequencing Identifies 26 Novel Candidate Genes in 192 Consanguineous Families”, published in Molecular Psychiatry, has implications for the…
Published on July 12, 2016
Researchers from The University of Texas at San Antonio (UTSA) have harnessed the power of next-generation sequencing to develop innovative strategies for tracking disease-causing pathogens like E. coli. The investigators hope their new study—“Whole Genome Sequencing for Genomics-Guided Investigations of Escherichia coli O157: H7 Outbreaks”—published recently in Frontiers in Microbiology,…
Published on May 1, 2015
Genomics has an obsession, and it’s called Big Data. However, unlike other obsessions, this one will probably not ruin anyone’s life—maybe only a few late nights or weekend plans for the researcher on a tight deadline. This preoccupation was born out of necessity. It began as an innate need to…
Published on September 18, 2014
Researchers at Northwestern Medicine say they have developed the first blood test to diagnose major depression in adults. The assay, which works by measuring the levels of nine RNA blood markers, also predicts who will benefit from cognitive behavioral therapy based on the behavior of some of the markers. In…